Objectif One third of the world's population is infected with latent TB, which therefore constitutes the largest reservoir for TB. In 5% of latently infected individuals TB will eventually re-activate, and it is believed that most new TB cases is indeed due to re-activation of latent TB. TB is a chronic disease, and during the long interaction with the host, the immune response against TB antigens tend to focus on only a few dominant epitopes. The idea for the project is that while a response against the dominant epitopes will lead to partial protection, it is not enough to eradicate M.tb resulting in a lifelong latent infection. Moreover, a response against dominant epitopes will wane with time resulting in re-activation of TB, and spreading of the disease. As a consequence, an immune response against only dominant epitopes within M.tb antigens is not enough to fully control the infection and stop the spread of the disease.Recently is has become increasingly clear that concerning chronic diseases, responses against subdominant epitopes, not induced by the natural infection, can be highly protective (1), and our working hypothesis is therefore the following: To increase the control over a chronic persisting M.tb infection (and prevent re-activation of TB), a response against the subdominant epitopes is required.To examine this we intend to test the vaccine efficacy of both dominant epitopes (epitopes induced by the natural infection) and sub-dominant epitopes (epitopes not induced by the natural infection) given post exposure to animals harbouring a persistent infection. Champ scientifique medical and health sciencesbasic medicineimmunologymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Programme(s) FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) Thème(s) FP7-PEOPLE-2009-IIF - Marie Curie Action: "International Incoming Fellowships" Appel à propositions FP7-PEOPLE-2009-IIF Voir d’autres projets de cet appel Régime de financement MC-IIF - International Incoming Fellowships (IIF) Coordinateur STATENS SERUM INSTITUT Contribution de l’UE € 206 629,00 Adresse ARTILLERIVEJ 5 2300 Kobenhavn S Danemark Voir sur la carte Région Danmark Hovedstaden Byen København Type d’activité Research Organisations Contact administratif Anne Enemark (Mrs.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée
